To validate the targeted killing capability of CAR-modified macrophages, we co-cultured CAR-Ms exhibiting an M1-like phenotype and potent cytotoxicity against HER2-positive tumor cells with PDO expressing high levels of HER2. The gene discussed is ERBB2; the disease is neoplasm.